Monitor Quote Charts Trades News Financials Toplists Alerts Portfolio Level 2 Message Boards
  25/07/2008
18:15:33
Site map		   Help
 
 
 
Peregrine Pharmaceuticals Inc.
(MM)
   
To register click here

Peregrine Pharmaceuticals Stock Price PPHM

Peregrine Pharmaceuticals stock quote | Peregrine Pharmaceuticals company information | Peregrine Pharmaceuticals Stock Chart | Peregrine Pharmaceuticals Stock News

Company Description : A biopharmaceutical company with a portfolio of clinical stage and pre-clinical product candidates using monoclonal antibodies for the treatment of cancer and viral diseases. url: www.peregrineinc.com

Name:
Peregrine Pharmaceuticals Inc. (MM)		 Symbol:
NASDAQ:PPHM		 Stock Market:
NASDAQ Stock Market		 Type:
Common Stock		 ISIN:
 Description:
 Change (p)Change (%)CurBidAskHighLowOpenVolumeTimeA
0.00741.800.41740.220.40.420.410.4118087317:47:44
To register Click hereRegister for free Peregrine Pharmaceuticals stock prices.

Peregrine Pharmaceuticals Receives Letter from NASDAQ Citing Failure to Regain Compliance with Minimum Bid Price Rule : - Company Will Request Hearing to Present Plans for Regaining Compliance - TUSTIN, Calif., July 23 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM), today announced that it received a Staff Determination...

Free Peregrine Pharmaceuticals Stock Charts

Peregrine Pharmaceuticals Historical Stock Chart
Peregrine Pharmaceuticals Historical Stock Chart
Peregrine Pharmaceuticals Monthly Stock Chart
Peregrine Pharmaceuticals Monthly Stock Chart		Peregrine Pharmaceuticals Intraday stock chart
Peregrine Pharmaceuticals Intraday stock chart

To register Click hereRegister for FREE streaming stock charts featuring overlays, annotations and more than 80 different studies including Level 2 Scope and Average True Range.

Get the Latest Peregrine Pharmaceuticals stock Price, quotes, trades and FREE Peregrine Pharmaceuticals stock charts, company information, annual reports, market news and announcements from ADVFN. We offer Intraday and historical stock prices for Peregrine Pharmaceuticals (PPHM) and other NASDAQ Stock Market listed companies as well as company financials, Level 2 Data and the latest investor information from our stock market Message Boards.

Peregrine Pharmaceuticals News & Message Board Discussion

Latest Peregrine Pharmaceuticals News Headlines
DateTimeSource
Headline
07/23/20084:05PMPRNUSPeregrine Pharmaceuticals Receives Letter from NASDAQ Citing Failure to Regain Compliance with Minimum Bid Price Rule
07/14/20087:00AMPRNUSPeregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2008
07/09/20089:00AMPRNUSPeregrine Pharmaceuticals to Report Fiscal Year 2008 Financial Results
07/02/20089:30AMPRNUSPeregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer
07/01/20087:50AMPRNUSPeregrine Pharmaceuticals Awarded DTRA Contract Worth up to $44.4 Million to Develop Bavituximab for Viral Hemorrhagic Fevers
06/30/20088:00AMPRNUSPeregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
06/25/20081:45AMPRNUSDSM and Crucell Sign Agreement with Avid Bioservices to Serve as First Pre-Approved U.S. Contract Manufacturer of PER.C6(R) Cell
06/16/20087:45AMPRNUSPeregrine Pharmaceuticals Awarded Two New U.S. Patents Broadening Its Targeted Anti-Phospholipid Patent Portfolio
06/02/20087:30AMPRNUSPeregrine Pharmaceuticals Presents Promising Phase I Data at ASCO and Provides Clinical Update on Its Phase II Bavituximab Breas
05/31/20087:30AMPRNUSData To Be Presented at ASCO Supports Potential of Peregrine's Cotara(R) for the Treatment of Brain Cancer
05/13/200810:00AMPRNUSPeregrine Pharmaceuticals Reports Studies Published in 'Science' Highlight Key Role of Phosphatidylserine (PS) in Viral Infectio
04/29/20089:00AMPRNUSPeregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Bavituximab Phase II Breast Cancer Trial
Latest Message Board Discussions
DateTimeSource
TitleMore
02/06/20066:59AMFreePPHM & CNVX both @ 52 week HIGHS with NICE charts! 

Peregrine Pharmaceuticals Company Information

 Sector  Turnover (m)  Profit (m)  EPS - Basic  PE ratio  Mkt Cap (m)  NMS 
  0.00 0.00   0.0 N/A
To register Click hereRegister for FREE access to the latest Peregrine Pharmaceuticals company information and fundamental data for other USA Common Stock companies. More than 100 separate statistics including accounts payable / sales and inventory / sales.

Latest Peregrine Pharmaceuticals Stock Trade

 Type  Size  Price  Date  Tr.Time  Units 
  300 0.4 07/25/2008 4:26PM USD


 



PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright1999-2008 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
ADDITIONAL SERVICES AVAILABLE FROM ADVFN
Upgrade - Click here for more information on ADVFN premium services Money Words - ADVFN Financial Glossary Investor Training ADVFN Financial Bookshop Online Training Academy
30 site:2us nasdaq pphm080725 18:15 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2005 | 2007 )